Garcia Marino

Garcia Marino is listed in filings as CEO AND PRESIDENT at Dianthus Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 17, 2026, including sale activity. Recent filings connect the profile to Dianthus Therapeutics, Inc. (DNTH). The current snapshot covers public activity from Feb 4, 2025 to Mar 17, 2026. Reported amounts are shown as $400.0K to $5.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.